In late July, Allergan began the process of recalling Biocell Textured Implants from the market. They are recalling implants that have not been placed; the FDA does not recommend removing implants from patients who are not experiencing symptoms of Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
